arBtrage CAPITALIZING MARKETS checking… Sign in Sign up

Recursion Pharmaceuticals, Inc.

RXRX Health Care Biotechnology: Biological Products (No Diagnostic Substances)
$3.31
▼ -12.8% Today
as of Jun 7, 07:26 ET
Last 30 days -2.79% Apr 28 → Jun 05
$2.77 $3.05 $3.32 $3.60 $3.88 Apr 28 May 05 May 13 May 20 May 29 Jun 05
Open
$3.63
High
$3.70
Low
$3.21
Volume
$27M
Avg Vol
$27M
Mkt Cap
$1.8B
P/E (TTM)
Beta
52w High
$7.18
52w Low
$2.77
Div Yield
Shares Out
$531M

Overview

52-week range
$2.77
$7.18
12% of range
Avg surprise (last 2)
+6.5%
Avg reaction (last 2)
-7.4%
50% positive
Latest IV / EM
153%
EM ±14.3% · $4 · Jun 12

Earnings trends

EPS — actual vs estimate Actual Estimate
$-0.50$-0.43$-0.36$-0.29$-0.22 Actual $-0.38Actual $-0.43Actual $-0.39Actual $-0.40Actual $-0.34Actual $-0.50Est $-0.44Actual $-0.41Actual $-0.36Actual $-0.22Est $-0.30 JunSepMarJunSepMar/2025JunSepMar/2026
Revenue vs Net Income Revenue Net income
$-202M$-145M$-88M$-30M$27M Jun 24Sep 24Mar 25Jun 25Sep 25Mar 26

Earnings history

DatePeriodActual EPSEstSurpriseYoY %ΔDay reactSource
Wed May 6, 2026Mar/2026 $-0.22 $-0.30 +26.7% +56.0% +1.8% earnings
Tue Sep 30, 2025Sep 2025 $-0.36 financials
Mon Jun 30, 2025Jun 2025 $-0.41 financials
Mon May 5, 2025Mar/2025 $-0.50 $-0.44 -13.6% -16.6% earnings
Mon Sep 30, 2024Sep 2024 $-0.34 financials
Sun Jun 30, 2024Jun 2024 $-0.40 financials
Sun Mar 31, 2024Mar 2024 $-0.39 financials
Sat Sep 30, 2023Sep 2023 $-0.43 financials
Fri Jun 30, 2023Jun 2023 $-0.38 financials

Financials

Income statement (quarterly)

MetricMar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024
Revenue$6M$5M$19M$15M$26M$14M
Cost of revenue$12M$15M$20M$22M$12M$9M
Gross profit
Operating income$-129M$-172M$-176M$-191M$-98M$-101M
Net income$-118M$-162M$-172M$-202M$-96M$-98M
EPS (diluted)$-0.22$-0.36$-0.41$-0.50$-0.34$-0.40

Balance sheet (quarterly)

MetricMar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024
Cash & equivalents$654M$743M$660M$525M$500M$594M$428M$474M
Inventory
Total current assets$710M$813M$714M$587M$584M$714M$474M$522M
Total assets$1.34B$1.47B$1.40B$1.30B$1.31B$1.45B$726M$776M
Long-term debt
Total liabilities$315M$343M$353M$383M$371M$414M$202M$191M
Total equity$1.02B$1.13B$1.05B$919M$934M$1.03B$525M$584M

Implied volatility — last 90 days

148%150%153%155%158% Jun 07 — IV 153% · EM ±14.3%

Sector peers

🔒 Preview mode. Create a free account to unlock the full earnings calendar, all panels, heatmaps, options flow, and screener.